Study S000340

Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01783717
Study type: INTERVENTIONAL
Masking: NONE
Status: UNKNOWN
Enrollment: 10
Start: 2012-12
Primary completion: 2015-01
Lead sponsor: Huashan Hospital
Conditions: Hypothalamic Obesity; Diabetes Mellitus
Interventions: DRUG:Exenatide
Results posted: FALSE

Registered primary outcomes

Change in body weight frome baseline to end of the study. [3 months]
BMI [baseline and 3 months]
HbA1c [baseline and 3 months]
Blood glucose level. [3 months.]
Beta cell function. [baseline and 3 months]
Insulin sensitivity. [baseline and 3 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.